EXCLUSIVE: RNC Chair backs TrumpRx, underscoring its growing political appeal

Republican National Committee Chairman Joe Gruters is touting President Donald Trump’s TrumpRx initiative as a key part of the GOP’s affordability message, a sign that Republicans increasingly view the program as both good policy and good politics heading into the midterms.

The endorsement is significant because it comes from the official responsible for electing Republicans nationwide. While numerous Republican lawmakers have praised TrumpRx, the chairman of the RNC publicly highlighting the initiative as part of the party’s electoral message may be the clearest indication yet that Republicans see it as a political winner.

TrumpRx has emerged as one of the administration’s signature affordability initiatives while avoiding the government price controls that many conservatives have long opposed. Instead, the effort has focused on working with industry and using market forces to drive down prescription drug costs, allowing Republicans to make an affordability argument without abandoning free-market principles.

The program has continued to grow, with Bristol Myers Squibb recently adding three drugs to TrumpRx that will provide up to 90% savings to patients who use the TrumpRx instead of purchasing through insurers or middlemen.

In an interview with the Washington Reporter’s Matthew Foldi, Gruters said the program reflects the president’s broader commitment to helping working Americans.

“That’s another way where the president has championed something for everybody, and he’s bringing prescription drug costs down and making sure that Americans have the benefit of paying what other countries pay and trying to get prices as low as possible,” Gruters said.

“It all goes back to affordability, and making sure that people can live the American Dream, and part of that is making sure that you can pay your bills and live a decent life. Between the Working Families Tax Cuts and Trump Rx, and everything else across the board, the guy’s been going to bat for the average American since day one.”

The comments add to a growing body of Republican support that the Washington Reporter has documented in recent months. Lawmakers including Sen. Jim Banks (R., Ind.), Rep. Andy Barr (R., K.Y.), Mike Haridopolos and Rep. Craig Goldman (R., Tex.) have praised TrumpRx as a conservative approach to lowering prescription drug costs. Previous Washington Reporter coverage has highlighted the program’s emphasis on competition and affordability rather than the government-directed pricing schemes favored by many Democrats.

One Republican strategist involved in multiple Senate races said Gruters’ comments should be viewed as an important political signal.

“When the chairman of the RNC starts talking about a policy as part of the party’s winning message, candidates notice, donors notice, and consultants notice,” the strategist said. “It tells you Republicans increasingly believe TrumpRx is one of the strongest affordability arguments they have heading into the midterms.”

With voters continuing to rank cost-of-living concerns among their top priorities, Republicans appear increasingly convinced that TrumpRx gives them a way to talk about health-care costs from a conservative perspective. Gruters’ endorsement suggests the initiative is no longer simply a White House policy effort. It is becoming a central part of the Republican political message for 2026.